Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.22.4
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The fair value of each stock option award granted during the year ended December 31,
2020 was estimated as of the grant date using a trinomial lattice model. Weighted average assumptions used during the years ended December 31, 2022, 2021 and 2020 are as follows:
  2022 2021 2020
Expected term (in years)
3.0 – 5.5
1.2 – 5.5
3.8 – 5.5
Risk-free interest rate (%)
1.4% - 4.5%
0.2% - 1.3%
0.2% - 1.7%
Expected volatility (%)
41.9% - 66.7%
38.7% - 51.4%
39.9% - 44.6%
Dividend yield (%)
Weighted average fair value/share at grant date $6.42 $18.87 $8.88
Schedule of Share-based Compensation, Stock Options, Activity
The status of the stock options are summarized as follows:
 
Number
of Shares
Weighted
Average Exercise
Price
Outstanding at December 31, 2019
5,318,759  $ 9.97 
     Granted 845,120  28.33 
     Exercised (2,310,934) 7.96 
     Forfeited (67,004) 16.37 
Outstanding at December 31, 2020
3,785,941  15.21 
     Granted 1,232,056  42.13 
     Exercised (1,372,564) 9.97 
     Forfeited (684,238) 29.70 
Outstanding at December 31, 2021
2,961,195  25.46 
     Granted 4,494,333  14.49 
     Exercised (949,259) 10.87 
     Forfeited (2,291,652) 26.50 
Outstanding at December 31, 2022
4,214,617  16.48 
Exercisable at December 31, 2022
873,808  27.53 
Schedule of Nonvested Share Activity
The number and weighted average grant-date fair values of options non-vested at the beginning and end of 2022, as well as options granted, vested, and forfeited during the year were as follows:
 
Number of Options
Weighted Average
Grant Date Fair Value
Non-vested at December 31, 2021
1,292,839  $ 13.93 
     Granted 4,494,333  6.42 
     Vested (684,633) $ 12.41 
     Forfeited (1,761,730) 10.27 
Non-vested at December 31, 2022
3,340,809  $ 6.11 
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable
The following table summarizes information about the options outstanding at December 31, 2022:
 
  Options Outstanding Options Exercisable
Range of
Exercise
Prices ($)
Number
Outstanding
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
Number
Exercisable
Weighted
Average
Remaining
Contractual
Life (Years)
Weighted
Average
Exercise
Price
7.34 – 8.13
876,001  6.42 $ 8.04  7,881  0.16 $ 8.03 
8.14 – 11.34
863,300  5.91 9.40  89,470  0.28 9.32 
11.35 – 12.61
504,781  6.05 11.87  47,294  0.48 11.94 
12.62 – 21.40
943,249  5.45 14.19  207,971  1.97 18.22 
21.41 – 55.40
1,027,286  4.34 33.98  521,192  3.19 36.08 
  4,214,617  5.55 16.48  873,808  2.43 27.53 
Schedule of Share-based Compensation, Restricted Stock Units Award Activity
The number of shares and weighted average grant date fair values of restricted non-vested common stock at the beginning and end of 2022, 2021 and 2020, as well as stock awards granted, vested, and forfeited during the year were as follows:
Number of
Restricted
Shares
Weighted Average
Grant Date
Fair Value
Nonvested at December 31, 2019
335,298  $ 15.75 
     Granted 149,012  28.45 
     Vested (184,127) 12.90 
     Forfeited (8,292) 20.75 
Nonvested at December 31, 2020
291,891  23.82 
     Granted 936,648  39.52 
     Vested (213,777) 32.83 
     Forfeited (163,359) 38.58 
Nonvested at December 31, 2021
851,403  36.00 
     Granted 2,865,727  14.16 
     Vested (413,747) 33.19 
     Forfeited (1,308,522) 24.57 
Nonvested at December 31, 2022
1,994,861  12.71